This metabolite provides a PDE selectivity profile comparable to sildenafil and an in vitro potency for PDE5 approximately fifty% of your parent drug. Plasma concentrations of the metabolite are close to forty% of People observed for sildenafil, so that the metabolite accounts for about twenty% of sildenafil's pharmacologic outcomes.This document w